Sponsor or institution

Clinical trials and research at Recursion Pharmaceuticals Inc.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Recursion Pharmaceuticals Inc. that are recruiting, at sites in 2 countries (most in United States (3), Canada (1)). By phase: Phase 1/2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
REC-7735 for PIK3CA-H1047R-mutant solid tumors Phase 1/2 Grand Rapids, Michigan and 2 other locations Recruiting Sep 14, 2026
Investigating REC-1245 for advanced or metastatic cancer Phase 1/2 Duarte, California and 6 other locations Recruiting Nov 7, 2024
Evaluating REC-4881 for treating Familial Adenomatous Polyposis Phase 1/2 Scottsdale, Arizona and 16 other locations Recruiting Sep 23, 2022

All recruiting trials (3)

Quick answers

How many clinical trials run by Recursion Pharmaceuticals Inc. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (3 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.